Core Viewpoint - Exor and the founder of Lifenet Healthcare have agreed to sell the Italian private healthcare group to insurer Reale Mutua, highlighting a trend of partnerships between insurers and private healthcare providers to manage costs and attract patients [1]. Company Summary - Lifenet Healthcare operates private hospitals, eye, and dental clinics across several regions in Italy, expecting revenues exceeding 450 million euros ($533 million) for the current year [1]. - The transaction values Lifenet Healthcare at approximately 600 million euros, with Reale Mutua acquiring 80% of the company while founder Nicola Bedin retains a 20% stake through his holding company Invin [1]. Industry Summary - The deal reflects a growing trend in the healthcare sector where insurers, private equity firms, and healthcare groups are increasingly collaborating, particularly focusing on outpatient clinics, day-surgery centers, and diagnostic services [1]. - JPMorgan acted as the lead financial adviser for the transaction, indicating the involvement of significant financial institutions in the healthcare deal-making landscape [1].

Third Point buys stake in Spanish defence firm Indra, source says | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Item 1 of 2 Dan Loeb, CEO and founder of Third Point, speaks during the 13D Monitor's Active-Passive Investor Summit in New York City, U.S., October 18, 2022. REUTERS/Brendan McDermid[1/2]Dan Loeb, CEO and founder of Third Point, speaks during the 13D Monitor's Active-Passive Investor Summit in New York City, U.S., Octo ...

Unsold bags of cocoa beans are stacked almost to the ceiling in Sekou Dagnogo's warehouse in Ivory Coast's western Duekoue town, where his cooperative is struggling to sell to exporters following a fall in global cocoa prices. ...

Aberdeen to vote against $9.2 billion FedEx-led InPost takeover | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]A woman stands at an InPost locker with an ASOS package at her feet in Hackney, London, Britain, January 26, 2021. REUTERS/Simon Newman/File Photo [Purchase Licensing Rights, opens new tab]Feb 16 (Reuters) - British money manager Aberdeen [(ABDN.L), opens new tab] will vote against the proposed 7.8 billion euro ($9.25 bil ...

Drugmaker Sanofi to expand India GCC, increase workforce to over 4,500 employees | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]The logo of French drugmaker Sanofi is seen in Paris, France, January 9, 2026. REUTERS/Gonzalo Fuentes/File Photo [Purchase Licensing Rights, opens new tab]- Companies[Sanofi SA]Follow[Eli Lilly and Co]Follow[Merck KGaA]FollowShow more companiesFeb 16 (Reuters) - French drugmaker Sanofi [(SASY.PA), opens ...

Core Insights - Eni has announced a significant gas and condensate discovery in Ivory Coast, named Calao South, which confirms the potential of the Calao channel complex and is the second-largest discovery in the country after Baleine [1] Company Summary - Eni operates in Ivory Coast with a 90% stake in Block CI-501, in partnership with state-owned Petroci Holding [1] - The Calao South discovery is estimated to contain up to 5.0 trillion cubic feet of gas and 450 million barrels of condensate, equivalent to approximately 1.4 billion barrels of oil [1] Industry Summary - The output from Baleine, the largest hydrocarbon development in Ivory Coast, is projected to increase to 150,000 barrels of oil and 200 million cubic feet of gas per day with the launch of Phase 3, highlighting its importance for the country's domestic energy needs [1]

Hungary asks Croatia for help after Russian oil flows via Ukraine halted | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Item 1 of 2 Fuga Bluemarine crude oil tanker lies at anchor near the terminal Kozmino in Nakhodka Bay near the port city of Nakhodka, Russia, December 4, 2022. REUTERS/Tatiana Meel[1/2]Fuga Bluemarine crude oil tanker lies at anchor near the terminal Kozmino in Nakhodka Bay near the port city of Nakhodka, Russia, ...

Core Viewpoint - Edwards Lifesciences has eliminated its anti-copycat policy, leading to the closure of an EU antitrust investigation against the company [1]. Group 1: Company Actions - Edwards Lifesciences has withdrawn its Global Unilateral Pro-Innovation (Anti-Copycatting) Policy (UPIP), which was previously a point of contention with Indian rival Meril [1]. - The European Commission confirmed that the removal of the UPIP from the company's website indicates that the concerns regarding market power abuse have been addressed [1]. Group 2: Regulatory Context - The European Commission had conducted an investigation into Edwards Lifesciences after a complaint from Meril, which alleged that the company was abusing its market position [1]. - The Commission's investigation included a raid on one of Edwards Lifesciences' facilities in September 2023 [1]. - The closure of the investigation means that further action is not considered a priority at the EU level [1].

Core Insights - China's Russian oil imports are projected to reach a new record high in February, driven by independent refiners taking advantage of significant discounts on Russian crude as India reduces its purchases due to U.S. pressure [1][1][1] Group 1: Import Data - Russian crude shipments to China are estimated at 2.07 million barrels per day (bpd) for February, an increase from January's estimated 1.7 million bpd [1][1] - Kpler's provisional data indicates February imports at 2.083 million bpd, up from 1.718 million bpd in January [1][1] Group 2: Market Dynamics - Since November, China has become Moscow's top client for seaborne shipments, as India's imports fell to a two-year low of 1.159 million bpd in February [1][1] - The discount on Russian oil prices has reached $9 to $11 per barrel below benchmark ICE Brent for January/February deliveries to China, marking the lowest in years for Urals crude [1][1] Group 3: Competitive Landscape - Independent Chinese refiners, known as teapots, are the largest consumers of U.S.-sanctioned oil from Russia, Iran, and Venezuela, with Russian oil becoming more competitive compared to Iranian supplies [1][1] - The ESPO blend is trading at $8 to $9 per barrel discounts to ICE Brent for March deliveries, while Iranian Light is assessed at $10 to $11 below ICE Brent [1][1] Group 4: Geopolitical Factors - Uncertainty regarding potential U.S. military strikes on Iran has led to reduced buying from Chinese teapots, making Russian oil appear more reliable [1][1] - Iranian oil deliveries to China have decreased to 1.03 million bpd in February from 1.25 million bpd in January, often disguised as Malaysian oil to bypass U.S. sanctions [1][1]

Core Insights - Major technology stocks have experienced significant declines in market value due to concerns over the return on investment from heavy AI spending, leading to a shift in investor sentiment from long-term ambitions to a demand for near-term earnings visibility [1] Company Performance - Microsoft shares have decreased by approximately 17% year-to-date, resulting in a market value loss of about $613 billion, bringing its valuation to around $2.98 trillion [1] - Amazon's stock has fallen by about 13.85%, erasing roughly $343 billion in market value, leaving it valued at approximately $2.13 trillion; the company anticipates a capital spending increase of over 50% this year [1] - Nvidia, Apple, and Alphabet have also seen declines in market value, with losses of $89.67 billion, $256.44 billion, and $87.96 billion, respectively, resulting in valuations of $4.44 trillion, $3.76 trillion, and $3.7 trillion [1] Market Trends - The decline in major tech stocks indicates a broader market shift, as investors are moving away from speculative enthusiasm for AI towards a focus on immediate financial performance [1] - In contrast, companies like TSMC, Samsung Electronics, and Walmart have gained market value, adding $293.89 billion, $272.88 billion, and $179.17 billion, respectively, with valuations reaching $1.58 trillion, $817 billion, and $1.07 trillion [1]